SQ 22,536
SIGMA/S153 - ≥97% (HPLC), powder
Synonym: 9-
CAS Number: 17318-31-9
Empirical Formula (Hill Notation): C9H11N5O
Molecular Weight: 205.22
MDL Number: MFCD00210216
Linear Formula: C9H11N5O
Product Type: Chemical
| assay | ≥97% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C9H11N5O/c10-8-7-9(12- |
| InChI key | UKHMZCMKHPHFOT-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Nc1ncnc2n(cnc12)C3CCCO3 |
| solubility | DMSO: >10 mg/mL |
| H2O: insoluble |
| Application: | SQ 22,536 was used to study the role of adenylate cyclase in differentiation of PC12 cells and in gap junctional intercellular communication in breast cancer cells. |
| Biochem/physiol Actions: | SQ 22,536 is a cell-permeable adenylyl cyclase inhibitor. IC50 = 20 μM in detergent-dispersed rat brain preparation. |
| Biochem/physiol Actions: | SQ 22,536 is an effective inhibitor of not only basal but also prosptaglandin E1-activated adenylate cyclase activities in platelets.1 It reverses hyperalgesia contralaterally and ipsilaterally when injected intramuscularly in rats.2 |
| Features and Benefits: | This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the Adenylyl cyclases page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| UNSPSC | 41106305 |

